The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease
Abstract
The extracellular accumulation of amyloid‐beta (Aβ) in neuritic plaques is one of the characteristic hallmarks of Alzheimer's disease (AD), a progressive dementing neurodegenerative disorder of the elderly. By virtue of its structure, Aβ is able to bind to a variety of biomolecules, including lipids, proteins and proteoglycans. The binding of the various forms of Aβ (soluble or fibrillar) to plasma membranes has been studied with regard to the direct toxicity of Aβ to neurons, and the activation of a local inflammation phase involving microglia. The binding of Aβ to membrane lipids facilitates Aβ fibrillation, which in turn disturbs the structure and function of the membranes, such as membrane fluidity or the formation of ion channels. A subset of membrane proteins binds Aβ. The serpin‐enzyme complex receptor (SEC‐R) and the insulin receptor can bind the monomeric form of Aβ. The α7nicotinic acetylcholine receptor (α7nAChR), integrins, RAGE (receptor for advanced glycosylation end‐products) and FPRL1 (formyl peptide receptor‐like 1) are able to bind the monomeric and fibrillar forms of Aβ. In addition, APP (amyloid precursor protein), the NMDA‐R (N‐methyl‐D‐aspartate receptor), the P75 neurotrophin receptor (P75NTR), the CLAC‐P/collagen type XXV (collagen‐like Alzheimer amyloid plaque component precursor/collagen XXV), the scavenger receptors A, BI (SR‐A, SR‐BI) and CD36, a complex involving CD36, α 6 β 1–integrin and CD47 have been reported to bind the fibrillar form of Aβ. Heparan sulfate proteoglycans have also been described as cell‐surface binding sites for Aβ. The various effects of Aβ binding to these membrane molecules are discussed. Copyright © 2004 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling
Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J.-H., Masiarz, F., Kan, Y. W., Goldfine, I. D., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90334-4 · Cited by 1,477
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Wolozin, B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,398
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,166
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Alzheimer’s amyloid fibrils: structure and assembly
Serpell, L. C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00029-6 · Cited by 959
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., & Teplow, D. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1125 · Cited by 787
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 783
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
Lansbury, P. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3342 · Cited by 553
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486
CD36 Mediates the Innate Host Response to β-Amyloid
El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021546 · Cited by 483
Nagele, R. G., D’Andrea, M. R., Anderson, W. J., & Wang, H.-Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00460-2 · Cited by 455
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430
Glycine binding primes NMDA receptor internalization
Nong, Y., Huang, Y.-Q., Ju, W., Kalia, L. V., Ahmadian, G., Wang, Y. T., & Salter, M. W. (2003) · Nature · doi:10.1038/nature01497 · Cited by 429
Du Yan, S., Zhu, H., Fu, J., Yan, S. F., Roher, A., Tourtellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 428
Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398 · cited 4×
“Furthermore, two different monoclonal antibodies to CD36 caused an approximately 50% inhibition of the H2O2 production of microglia and human macrophages adhering to surfaces coated with fAβ, which suggests a role of CD36 in fAβ-induced H2O2 production by microglia, also implying that CD36 can mediate binding to fAβ […”
BackgroundInfluentialKakio, A., Nishimoto, S.-I., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2002) · Biochemistry · doi:10.1021/bi0255874 · Cited by 387
Bokvist, M., Lindström, F., Watts, A., & Gröbner, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.046 · Cited by 375
Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein
Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 359
Husemann, J., Loike, J. D., Anankov, R., Febbraio, M., & Silverstein, S. C. (2002) · Glia · doi:10.1002/glia.10148 · Cited by 358
Interaction of Alzheimer β-Amyloid Peptide(1−40) with Lipid Membranes
Terzi, E., Hölzemann, G., & Seelig, J. (1997) · Biochemistry · doi:10.1021/bi971843e · Cited by 353
Yaar, M., Zhai, S., Pilch, P. F., Doyle, S. M., Eisenhauer, P. B., Fine, R. E., & Gilchrest, B. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119772 · Cited by 336
McLaurin, J., & Chakrabartty, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26482 · Cited by 335
Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse
Chavis, P., & Westbrook, G. (2001) · Nature · doi:10.1038/35077101 · Cited by 332
β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
Liu, Q.-S., Kawai, H., & Berg, D. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081553598 · Cited by 331
The role of cholesterol in the biosynthesis of β-amyloid.
Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. M. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00014 · Cited by 324
Choo-Smith, L.-P., Garzon-Rodriguez, W., Glabe, C. G., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.22987 · Cited by 312
Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor
Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., van Bronswijk, W., & Martins, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0001.2002 · Cited by 291
Vlodavsky, I., Miao, H.-Q., Medalion, B., Danagher, P., & Ron, D. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437470 · Cited by 286
Wiltfang, J., Esselmann, H., Bibl, M., Smirnov, A., Otto, M., Paul, S., Schmidt, B., Klafki, H. ‐., Maler, M., Dyrks, T., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00818.x · Cited by 271
Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J.-L., Murphy, P. M., Oppenheim, J. J., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 270
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
McLaurin, J., Franklin, T., Zhang, X., Deng, J., & Fraser, P. E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00957.x · Cited by 258
Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., & Makita, Z. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03075-4 · Cited by 253
Integrin Subunit Gene Expression Is Regionally Differentiated in Adult Brain
Pinkstaff, J. K., Detterich, J., Lynch, G., & Gall, C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01541.1999 · Cited by 250
β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 240
Kremer, J. J., Pallitto, M. M., Sklansky, D. J., & Murphy, R. M. (2000) · Biochemistry · doi:10.1021/bi0001980 · Cited by 237
Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins
Mahfoud, R., Garmy, N., Maresca, M., Yahi, N., Puigserver, A., & Fantini, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111679200 · Cited by 232
The channel hypothesis of Alzheimer’s disease: current status
Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R., & Lin, M.-C. (2002) · Peptides · doi:10.1016/s0196-9781(02)00067-0 · Cited by 230
Integrins take partners: cross-talk between integrins and other membrane receptors
Porter, J. C., & Hogg, N. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01344-0 · Cited by 227
Hashimoto, T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1524 · Cited by 227
Peng, X., Katz, M., Gerzanich, V, Anand, R., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10029-1 · Cited by 222
Sergeant, N., Bombois, S., Ghestem, A., Drobecq, H., Kostanjevecki, V., Missiaen, C., Wattez, A., David, J., Vanmechelen, E., Sergheraert, C., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01818.x · Cited by 218
Interactions of Amyloid β-Peptide (1−40) with Ganglioside-Containing Membranes
Matsuzaki, K., & Horikiri, C. (1999) · Biochemistry · doi:10.1021/bi982345o · Cited by 217
Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M. R., Mark, R. J., Blanc, E. M., Roth, G. S., & Mattson, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6753 · Cited by 209
Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R. A., Greenberg, B., & Kisilevsky, R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98776-4 · Cited by 207
Cholesterol, a modulator of membrane-associated aβ-fibrillogenesis and neurotoxicity
Yip, C. M., Elton, E. A., Darabie, A. A., Morrison, M. R., & McLaurin, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4881 · Cited by 207
Clearance of amyloid β-peptide from brain: transport or metabolism?
Zlokovic, B. V., Yamada, S., Holtzman, D., Ghiso, J., & Frangione, B. (2000) · Nature Medicine · doi:10.1038/77397 · Cited by 186
Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., & Selkoe, D. J. (1998) · Biochemistry · doi:10.1021/bi972029u · Cited by 186
α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation
Wang, H.-Y., Li, W., Benedetti, N. J., & Lee, D. H. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212532200 · Cited by 185
Solano, D. C., Sironi, M., Bonfini, C., Solerte, S. B., Govoni, S., & Racchi, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.1015 · Cited by 177
Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
Giulian, D., Haverkamp, L. J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., & Roher, A. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29719 · Cited by 164
Tiffany, H. L., Lavigne, M. C., Cui, Y., Wang, J., Leto, T. L., Gao, J., & Murphy, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101031200 · Cited by 161
Chalmers, K., Wilcock, G. K., & Love, S. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00457.x · Cited by 156
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 153
A Novel Action of Alzheimer's Amyloid β-Protein (Aβ): Oligomeric Aβ Promotes Lipid Release
Michikawa, M., Gong, J., Fan, Q., Sawamura, N., & Yanagisawa, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07226.2001 · Cited by 152
Brain membrane cholesterol domains, aging and amyloid beta-peptides
Wood, W. B., Schroeder, F., Igbavboa, U., Avdulov, N. A., & Chochina, S. V. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00018-0 · Cited by 149
Yaar, M., Zhai, S., Fine, R. E., Eisenhauer, P. B., Arble, B. L., Stewart, K. B., & Gilchrest, B. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110929200 · Cited by 148
Link between heart disease, cholesterol, and Alzheimer's disease: A review
Sparks, D. L., Martin, T. A., Gross, D. R., & Hunsaker, J. C. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<287::aid-jemt7>3.0.co;2-l · Cited by 147
?-amyloid binds to p75NTRand activates NF?B in human neuroblastoma cells
Kuner, P., Schubenel, R., & Hertel, C. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981215)54:6<798::aid-jnr7>3.0.co;2-t · Cited by 145
Malherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., & Huber, G. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00174-6 · Cited by 143
Eckert, G. P., Cairns, N. J., Maras, A., Gattaz, W. F., & Müller, W. E. G. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017234 · Cited by 137
Blanc, E. M., Kelly, J. F., Mark, R. J., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020570.x · Cited by 136
Ghiso, J. A., Rostagno, A. A., Gardella, J. E., Liem, L.-K., Gorevic, P. D., & Frangione, B. (1992) · Biochemical Journal · doi:10.1042/bj2881053 · Cited by 133
Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases
Díaz‐Nido, J., Wandosell, F. G., & Ávila, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00068-2 · Cited by 133
Koldamova, R. P., Lefterov, I. M., Lefterova, M. I., & Lazo, J. S. (2001) · Biochemistry · doi:10.1021/bi002186k · Cited by 131
The role of integrins in immune-mediated diseases of the nervous system
Archelos, J. J., Previtali, S. C., & Hartung, H.-P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01287-9 · Cited by 130
Apolipoprotein E: a major piece in the Alzheimer's disease puzzle
Cedazo-Mínguez, Á., & Cowburn, R. F. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00159.x · Cited by 123
Mason, R. P., Jacob, R. F., Walter, M. F., Mason, P. E., Avdulov, N. A., Chochina, S. V., Igbavboa, U., & Wood, W. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18801 · Cited by 123
Husemann, J., Loike, J. D., Kodama, T., & Silverstein, S. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00239-9 · Cited by 122
Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of Pharmacotherapy
Harkany, T., Ábrahám, I. M., Kónya, C., Nyakas, C. J., Zarándi, M., Penke, B., & Luiten, P. G. M. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.4.329 · Cited by 122
Self-citationExpression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
Rabizadeh, S., Bitler, C. M., Butcher, L. L., & Bredesen, D. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10703 · Cited by 121
Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113
YAZAWA, H., YU, Z.-X., TAKEDA, K., LE, Y., GONG, W., FERRANS, V. J., OPPENHEIM, J. J., LI, C. C. H., & WANG, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0251com · Cited by 105
The α5β1 Integrin Mediates Elimination of Amyloid-β Peptide and Protects Against Apoptosis
Matter, M. L., Zhang, Z., Nordstedt, C., & Ruoslahti, E. I. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1019 · Cited by 104
Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor.
Joslin, G., Krause, J. E., Hershey, A. D., Adams, S., Fallon, R. J., & Perlmutter, D. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54721-9 · Cited by 103
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103
Koudinov, A. R., Berezov, T. T., Kumar, A. R., & Koudinova, N. V. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00207-6 · Cited by 102
Cellular Membrane Composition Defines Aβ-Lipid Interactions
Waschuk, S. A., Elton, E. A., Darabie, A. A., Fraser, P. E., & McLaurin, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103598200 · Cited by 99
Cholesterol, Aβ and Alzheimer's disease
Hartmann, T. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01990-1 · Cited by 99
Amyloid β-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region
Chochina, S. V., Avdulov, N. A., Igbavboa, U., Cleary, J. P., O‘Hare, E., & Wood, W. G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31580-7 · Cited by 97
Zhang, Y., Hong, Y., Bounhar, Y., Blacker, M., Roucou, X., Tounekti, O., Vereker, E., Bowers, W. J., Federoff, H. J., Goodyer, C. G., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07385.2003 · Cited by 93
Bi, X., Gall, C. M., Zhou, J., & Lynch, G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00132-x · Cited by 92
Van Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E., & Masliah, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09298.2002 · Cited by 91
Boland, K., Behrens, M. I., Choi, D. W., Manias, K., & Perlmutter, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18032 · Cited by 91
Strohmeyer, R., Ramirez, M., Cole, G. J., Mueller, K., & Rogers, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00272-2 · Cited by 89
Michikawa, M. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:1:1 · Cited by 88
Tsukamoto, E., Hashimoto, Y., Kanekura, K., Niikura, T., Aiso, S., & Nishimoto, I. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10703 · Cited by 86
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide
Buée, L., Ding, W., Delacourte, A., & Fillit, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91706-x · Cited by 82
Fagan, A. M., & Holtzman, D. M. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<297::aid-jemt9>3.0.co;2-c · Cited by 82
Memory Function and Brain Glucose Metabolism
Hoyer, S. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40452 · Cited by 81
Cui, Y., Le, Y., Yazawa, H., Gong, W., & Wang, J. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.628 · Cited by 79
Diversity of Amyloid β Protein Fragment [1–40]-Formed Channels
Kourie, J. I., Henry, C. L., & Farrelly, P. V. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1010995121153 · Cited by 76
Lee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67
Kajkowski, E. M., Lo, C. F., Ning, X., Walker, S., Sofia, H. J., Wang, W., Edris, W., Chanda, P., Wagner, E., Vile, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011161200 · Cited by 63
Interaction of beta-amyloid peptides with integrins in a human nerve cell line
Sabo, S. L., Lambert, M. P., Kessey, K., Wade, W. S., Krafft, G. A., & Klein, W. L. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11159-g · Cited by 62
Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor
Xie, L., Martins, R. N., Racchi, M., Craft, S., & Helmerhorst, E. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4504 · Cited by 61
Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview
Tran, M. H., Yamada, K., & Nabeshima, T. (2002) · Peptides · doi:10.1016/s0196-9781(02)00062-1 · Cited by 61
Koudinov, A. R., Berezov, T. T., & Koudinova, N. V. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02263-7 · Cited by 54
Alzheimer's disease: molecular concepts and therapeutic targets
Fassbender, K. C., Masters, C. L., & Beyreuther, K. T. (2001) · Die Naturwissenschaften · doi:10.1007/s001140100237 · Cited by 52
Kimura, H., & Schubert, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7508 · Cited by 51
Boland, K. A., Manias, K., & Perlmutter, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28022 · Cited by 47
Mizuno, T., Haass, C., Michikawa, M., & Yanagisawa, K. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00097-2 · Cited by 47
Cholesterol, Synaptic Function and Alzheimer’s Disease
Koudinov, A. R., & Koudinova, N. V. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43055 · Cited by 44
Jonnala, R. R., Graham, J. H., Terry, A. V., Beach, J. W., Young, J. A., & Buccafusco, J. J. (2003) · Synapse · doi:10.1002/syn.10176 · Cited by 38
Beta Amyloid Toxicity Does Not Require RAGE Protein
Liu, Y., Dargusch, R., & Schubert, D. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7068 · Cited by 35
Good, T. A., & Murphy, R. M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1174 · Cited by 32
High density lipoprotein decreases β-amyloid toxicity in cortical cell culture
Farhangrazi, Z. S., Ying, H. S.-C., Bu, G., Dugan, L. L., Fagan, A. M., Choi, D. W., & Holtzman, D. M. (1997) · Neuroreport · doi:10.1097/00001756-199703240-00013 · Cited by 28
The Functions of the Amyloid Precursor Protein Gene
Panegyres, P. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 25
Aggregation-Dependent Interaction of the Alzheimers β-Amyloid and Microglia
Muehlhauser, F., Liebl, U., Kuehl, S., Walter, S., Bertsch, T., & Fassbender, K. C. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.048 · Cited by 24
White, A. R., Maher, F., Brazier, M. W., Jobling, M. F., Thyer, J., Stewart, L. R., Thompson, A., Gibson, R., Masters, C. L., Multhaup, G., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04173-2 · Cited by 23
Li, X. D., & Buccafusco, J. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053785 · Cited by 23
The Brain's Microenvironment, Early Functional Loss, and the Conversion to Alzheimer's Disease
Cotman, C. W., & Anderson, A. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05569.x · Cited by 21
Evidence that glypican is a receptor mediating β-amyloid neurotoxicity in PC12 cells
Schulz, J. G., Megow, D., Reszka, R. C., Villringer, A., Einhäupl, K. M., & Dirnagl, U. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00220.x · Cited by 18
Molecular Identification of AMY, an Alzheimer Disease Amyloid-Associated Protein
Söderberg, L., Zhukareva, V. A., Bogdanović, N., Hashimoto, T., Winblad, B. G., Iwatsubo, T., Lee, V. M. ‐., Trojanowski, J. Q., & Näslund, J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.11.1108 · Cited by 17
The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?
Talaga, B. S. P. P., & Quere, B. S. P. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023338897 · Cited by 16
Takenouchi, T., & Munekata, E. (1995) · Peptides · doi:10.1016/0196-9781(95)00084-w · Cited by 14
Amyloid β-peptide alters thrombin-induced calcium responses in cultured human neural cells
Mattson, M. P., & Begley, J. G. (1996) · Amyloid · doi:10.3109/13506129609014352 · Cited by 14
Antic, A., Dzenko, K. A., & Pachter, J. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7265 · Cited by 13
(1997) · PubMed
Cited by
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
A network dysfunction perspective on neurodegenerative diseases
Palop, J. J., Chin, J., & Mucke, L. (2006) · Nature · doi:10.1038/nature05289 · Cited by 692
Metadata
- Authors
- Verdier, Y., Zarándi, M., & Penke, B.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2004-04-26
- Volume
- 10
- Issue
- 5
- Pages
- 229-248
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W2029651181
- Cited by
- 262
- References
- 143
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.